Convergence 360, using a consultative and collaborative approach, provides clients with a complete array of integrated services to launch and maintain their products in the market. The 360 operational team is comprised of the principals of strategically linked organizations, each with the expertise essential for the success of our clients.

Additionally, our complete service offering allows us to see the big picture from a commercialization perspective, allowing an allocation of resources across the range of services that best meet the needs of the customer, as opposed to a potentially myopic viewpoint of a provider focused on a single service offering.

The organizational goal is to provide a full spectrum, or a "convergence" of commercialization services as they are needed for late-life drugs and new drugs beginning in Phase IV clinical trials.